Epidemiology of keratitis/scleritis-related endophthalmitis in a university hospital in Thailand
- PMID: 34045630
- PMCID: PMC8160326
- DOI: 10.1038/s41598-021-90815-1
Epidemiology of keratitis/scleritis-related endophthalmitis in a university hospital in Thailand
Abstract
To demonstrate the demographics, associated factors, clinical presentations, microbiology, management, visual outcome and complications of keratitis/scleritis-related endophthalmitis (KSE). A retrospective chart of all endophthalmitis patients diagnosed between September 2001 and August 2011 was reviewed. Only endophthalmitis cases with previous corneal or scleral infection were included in the study. The patients were followed until losing vision or eyeball, becoming phthisis, or the end of 2018. Eighty-seven patients with KSE were identified, all unilateral. The mean age was 56.4 ± 21.4 years. There was a slight male predilection (55 patients, 63.2%). The mean follow-up time was 50 ± 149 weeks. The causative pathogens were identified in 35 patients (40.2%), with the highest frequency being bacteria. The most common bacterium was Pseudomonas aeruginosa (n = 13), and the most common fungus was Aspergillus sp. (n = 5). Fifteen patients achieved (17.2%) final visual acuity (VA) of hand motion or better after treatment. Eyeball removal was performed in 61 (70.1%) patients. From multivariate analysis, the only prognostic factor for poor final VA (worse than hand motion, HM) was poor VA (worse than HM) at the initial visit (relative risk 1.97, 95% confidence interval 1.15-3.36, p = 0.013). KSE is uncommon but has a devastating outcome. We found that the patient's initial VA was the only predictor for their final vision. P. aeruginosa was the most common identifiable organism in this study. However, several fungal infections were recognised. These findings should raise awareness for treatment of KSE in the tropics.
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Microbial keratitis-induced endophthalmitis: incidence, symptoms, therapy, visual prognosis and outcomes.BMC Ophthalmol. 2018 May 3;18(1):112. doi: 10.1186/s12886-018-0777-3. BMC Ophthalmol. 2018. PMID: 29724209 Free PMC article.
-
Bacterial Keratitis: Clinical Features, Causative Organisms, and Outcome During a 13-year Study Period.Cornea. 2023 Jun 1;42(6):702-707. doi: 10.1097/ICO.0000000000003179. Epub 2022 Nov 21. Cornea. 2023. PMID: 36730384
-
Infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes.Ophthalmology. 2012 Dec;119(12):2443-9. doi: 10.1016/j.ophtha.2012.06.030. Epub 2012 Aug 1. Ophthalmology. 2012. PMID: 22858123 Free PMC article.
-
Nontuberculous mycobacterial endophthalmitis: case series and review of literature.BMC Infect Dis. 2020 Nov 23;20(1):877. doi: 10.1186/s12879-020-05606-2. BMC Infect Dis. 2020. PMID: 33228593 Free PMC article. Review.
-
Endogenous bacterial endophthalmitis: an east Asian experience and a reappraisal of a severe ocular affliction.Ophthalmology. 2000 Aug;107(8):1483-91. doi: 10.1016/s0161-6420(00)00216-5. Ophthalmology. 2000. PMID: 10919895 Review.
Cited by
-
Ten-Year Analysis of Pathogenic Factors and Etiological Characteristics of Endophthalmitis from a Tertiary Eye Center in North China.Infect Drug Resist. 2022 Jun 10;15:3005-3012. doi: 10.2147/IDR.S367222. eCollection 2022. Infect Drug Resist. 2022. PMID: 35711516 Free PMC article.
-
Infectious scleritis: a comprehensive narrative review of epidemiology, clinical characteristics, and management strategies.Ther Adv Ophthalmol. 2025 Jul 23;17:25158414251357776. doi: 10.1177/25158414251357776. eCollection 2025 Jan-Dec. Ther Adv Ophthalmol. 2025. PMID: 40718796 Free PMC article. Review.
-
History and Perspective of Immunotherapy for Pythiosis.Vaccines (Basel). 2021 Sep 26;9(10):1080. doi: 10.3390/vaccines9101080. Vaccines (Basel). 2021. PMID: 34696188 Free PMC article. Review.
-
Reply to editor comment on Alternaria chartarum sclerokeratouveitis: A new fungus cause.Taiwan J Ophthalmol. 2021 Oct 27;12(2):244-245. doi: 10.4103/tjo.tjo_36_21. eCollection 2022 Apr-Jun. Taiwan J Ophthalmol. 2021. PMID: 35813805 Free PMC article. No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources